Mercer Global Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
Mercer Global Advisors's RCKT Position: Q3 2026 in Review
Mercer Global Advisors reduced its Rocket Pharmaceuticals (RCKT) stake by 61% in Q3 2026, selling an estimated $229K and leaving 41,821 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #3581.
Mercer Global Advisors first reported a position in RCKT in Q3 2025 and has held it in 5 quarters since. The position peaked at $369K in Q2 2026. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- Mercer Global Advisors held 41,821 shares of Rocket Pharmaceuticals worth $110K as of Q3 2026.
- Mercer Global Advisors sold 66,207 Rocket Pharmaceuticals shares in Q3 2026, an estimated $229K.
- Rocket Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #3581 holding.
- Mercer Global Advisors first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Mercer Global Advisors's Rocket Pharmaceuticals position peaked at $369K in Q2 2026.
- 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.